Singapore, July 21 -- Singaporean researchers have developed an artificial intelligence-powered scoring system capable of predicting the recurrence of liver cancer, according to a press release from the Agency for Science, Technology and Research on Monday.
Developed by scientists from the Institute of Molecular and Cell Biology (IMCB) under the agency in collaboration with the Singapore General Hospital, the system can forecast the recurrence of hepatocellular carcinoma, the most common type of liver cancer, with approximately 82 per cent accuracy.
The system works by analyzing the spatial distribution of natural killer immune cells and five key genes within liver tumor tissues.
"In Singapore, up to 70 per cent of liver cancer patients ...